Evaluation of the Safety of Folate Receptor-Targeted Boron Carrier in Boron Neutron Capture Therapy (BNCT) for Malignant Gliomas Using CED Administration

Knowing how to accumulate boron into the tumor cells is a crucial aspect of boron neutron capture therapy (BNCT), which can be targeted at the cellular level, and the development of novel boron agents other than BPA, which is used in clinical practice, is urgently needed [...]

Détails bibliographiques

Auteurs principaux:	Kohei Tsujino, Hideki Kashiwagi, Ryo Kayama, Yoshiki Fujikawa, Yusuke Fukuo, Ryo Hiramatsu, Naosuke Nonoguchi, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Naonori Hu, Masahiko Wanibuchi, Kei Nakai, Kai Nishimura, Hiroyuki Nakamura, Shinji Kawabata
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2024-03-01
Collection:	Proceedings
Sujets:	boron neutron capture therapy gliomas convection-enhanced delivery (CED) folate receptor
Accès en ligne:	https://www.mdpi.com/2504-3900/100/1/15
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!